Physician profile
Felicia Chen
NPI 1063829935
$5,853.36
in general payments reported to CMS, 2019-2025
21 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $105 · 2021: $432 · 2022: $873 · 2023: $645 · 2024: $1,169 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,423 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750 · Entertainment: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,423.28 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750.00 |
| Entertainment | $331.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,422.11 | 2022-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $1,090.47 | 2019-2025 | Acuvue |
| Coopervision INC. | $519.95 | 2020-2025 | Misight Contact Lens, Clariti Contact Lens, Synergeyes Contact Lens |
| Optos, INC. | $375.23 | 2019-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $356.16 | 2022-2024 | Cequa |
| Shire North American Group INC | $234.88 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $217.83 | 2019 | |
| Alcon Vision LLC | $210.39 | 2024-2025 | Precision7, Precision 1, Total30 |
| Eyevance Pharmaceuticals LLC | $202.10 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $193.66 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $181.41 | 2023-2025 | Oxervate |
| Carl Zeiss Meditec, INC. | $160.89 | 2019-2020 | |
| Rxsight INC | $145.30 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Kala Pharmaceuticals, INC. | $123.00 | 2021 | |
| Harrow Eye, LLC | $113.51 | 2025 | Vevye |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $111.75 | 2024 | Omni Surgical System |
| Biotissue Holdings INC. | $92.32 | 2024 | |
| Novartis Pharmaceuticals Corporation | $34.89 | 2022-2023 | |
| Oyster Point Pharma, INC. | $25.01 | 2024 | Tyrvaya |
| Lkc Technologies, INC. | $23.10 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felicia Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.